Omico

20/08/2026

From new biomarker screening to regional clinical trials and inherited cancer research — there’s plenty happening across Omico.

Our July eNewsletter brings together some of the latest updates, including:
🔬 A new biomarker screening pilot for gynaecological cancers
🧬 Insights from Omico’s SMOC+ research into inherited cancers
📍 How Orange, NSW is helping deliver regional access to clinical trials
📅 APOS 27 dates, our first speaker announcement and sponsorship opportunities

🔗 Read the July 2026 issue: https://drnr-hgp.campaign-view.com.au/ua/SharedView?od=3z9c8dd35b5d267912294a78267313be066def71e3ecf55ebed680024acbc198b3&cno=11a2b0b20913af1&cd=1628e4ae2fe9aed&m=0

✉️ Subscribe to receive future editions: https://omico.org.au/webform/

Our next issue will be released in late September.

20/08/2026

📣 We’re growing the team supporting Omico’s Molecular Oncology Board.

We’re looking for a Research Officer to join the Centre for Molecular Oncology at UNSW and contribute to the research that supports Omico’s Molecular Oncology Board (MOB).

It’s an opportunity to work within a multidisciplinary team on innovative clinical research in molecular oncology, including research supporting Omico’s national Cancer Screening Program (CaSP).

If you have clinical research experience and enjoy working collaboratively across research, data and clinical environments, this could be one for you.

🔬 Research Officer | Centre for Molecular Oncology, UNSW
📍 Kensington, Sydney | Full-time
📅 Applications close Sunday 30 August, 11.30pm

Interested — or know someone who could be a great fit?
Find out more and apply: https://external-careers.jobs.unsw.edu.au/cw/en/job/542123/research-officer



UNSW University of Sydney UNSW Medicine & Health Cancer Institute NSW

17/08/2026

Every person who participates.
Every clinician who refers.
Every researcher who investigates.
Every partner who supports our initiatives.
They are all helping science move forward.

This , we recognise the thousands of people contributing to precision oncology research through Omico, helping generate knowledge and evidence that can benefit people living with cancer today and tomorrow.

💙 Thank you for being part of it.



UNSW University of Sydney UNSW Medicine & Health Cancer Institute NSW

13/08/2026

On , we’re recognising the cancer nurses who help make new treatment opportunities possible for people living with cancer.

At Omico, we help Australians access biomarker-led clinical trials and advanced therapies. But matching a patient to a trial is only one part of the journey.

Cancer nurses play a vital role in helping patients participate in trials, from supporting them through treatment, navigating complexity and providing continuity of care.

We hear it directly from participants in Omico programs. When they talk about their clinical trial experience, their nurses are often among the people they single out — “wonderful” and “incredible” are words we’ve heard recently.

💙 Thank you to cancer nurses across Australia for the expertise, care and commitment you bring to patients and clinical trials every day.



Cancer Nurses Society of Australia - CNSA

07/08/2026

🧬 Identifying an inherited cancer risk is only the beginning.

Around 10–16% of children and young people diagnosed with cancer have a heritable cancer predisposition — a genetic change present from birth that increases their cancer risk and may run in their family.

Omico’s research study is investigating surveillance — regular screening for early signs of cancer — for young people at increased risk of developing cancers in different parts of the body.

➡️Among 20 participants, the study has detected four new primary cancers in three individuals. These were new, separate cancers rather than recurrences or the spread of an existing cancer.

➡️SMOC Junior is also exploring the emotional and practical impacts of surveillance. Early findings from participating parents highlight the importance of clear communication, coordinated care and psychological support.

These early findings help build understanding of inherited cancer risk and why ongoing surveillance matters for young people and their families.

Study activity has taken place across two children’s hospitals, with further sites preparing to commence.

💻 Learn more about and Omico’s work in inherited cancer risk: https://omico.org.au/our-programs/surveillance-study-in-multi-organ-cancer-prone-syndromes-smoc/

06/08/2026

Did you know some dedicated (and perhaps slightly crazy!) golfers play for 12 or even 24 hours straight to raise money for cancer research? ⛳💛

That's exactly what Rodney Frost and the incredible One Day community do each year.

Through their partnership with Love Your Sister, they've helped fund cancer research that is making a real difference — including precision oncology initiatives at Omico.

We've been privileged to attend ONE DAY over the past two years alongside Love Your Sister founder Samuel Johnson, meeting the inspiring golfers, volunteers, sponsors and supporters who make this extraordinary event possible.

It's always a reminder of what can be achieved when a community comes together with one goal: helping more people living with cancer access better treatment options and brighter futures.

A huge thank you to Rodney and everyone involved in ONE DAY for your extraordinary commitment to changing lives.

⛳ Love golf and keen to make a difference?
Whether you're ready to take on the 12- or 24-hour challenge, or simply support someone who is, you'll be helping fund research that has a real impact.

Check out ONE DAY's post below to learn more and register.

Castle Hill Country Club Golf Course

An annual Australian golf event. We play for 24 hours straight. 100% of funds to Cancer Research. During One Day we spend 24 hours straight playing golf

30/07/2026

So many of us have a friend whose life has been affected by cancer, or have relied on a friend during our own experience.

This , we recognise the many ways friends provide support: listening, helping with everyday things, sharing moments of normality or simply staying close.

💙 Sometimes, being there is enough.

22/07/2026

Behind every clinical trial opportunity is a network of people and organisations working together.

It takes collaboration across the cancer ecosystem to connect the right patient with the right clinical trial.

Emily Capper’s story from Orange is a powerful example of what can happen when clinicians, hospitals, research teams, global industry partners and precision oncology programs work together.

Through comprehensive genomic profiling via Omico’s initiative, Emily was matched to a Fore Biotherapeutics clinical trial at Orange Hospital and Central West Cancer Care Centre, where Dr Rob Zielinski and his team are helping expand access to innovative cancer research in regional Australia.

These collaborations can help bring novel targeted therapy trials to Australia, while creating more opportunities for eligible patients to access biomarker-led clinical trials closer to home.

💙 Thank you to everyone who makes this work possible — from patients who participate in research, to clinicians, hospitals, research teams and industry partners committed to improving outcomes for people living with cancer.

🎥 Watch the Channel 7 news story: https://www.facebook.com/reel/2209608723136759
📖 Read the full article: https://www.centralwesterndaily.com.au/story/9305489/emily-capper-regional-cancer-trial-extends-life-past-prognosis/ (subscriber access)



UNSW UNSW Medicine & Health Cancer Institute NSW

21/07/2026

👀 Curious to know more?

Our newsletter shares updates on Omico’s research, initiatives, partnerships and progress—all focused on making precision oncology more accessible for Australians with cancer.

Subscribe and stay informed to the latest from Omico:
👉 https://www.omico.com.au/webform/

There’s always something new happening in precision oncology.

16/07/2026

"There’s no good reason I can think of why regional cancer centres can’t offer all the bells and whistles of trials that metro centres can." – Dr Rob Zielinski

Regional cancer centres are changing what's possible for people living with cancer.

As highlighted in recent media coverage from Orange, Dr Zielinski and his team are expanding access to innovative clinical trials, with patients now travelling from Sydney and Canberra to Orange to participate in research.

💬 Dr Zielinski also highlighted the role of Omico's initiative in connecting eligible patients with clinical trial opportunities through comprehensive genomic profiling:
"We wouldn’t have known about us having this trial open in Orange unless they had this Omico platform."

👏 Congratulations to Dr Zielinski and the teams from Orange Hospital and Central West Cancer Care Centre for their leadership in regional cancer care.

💙 And thank you to all the clinicians, research teams and industry partners working together to improve access to precision oncology across Australia.

🎥 Watch the Channel 7 news story: https://www.facebook.com/reel/2209608723136759
📖 Read the full article: https://www.centralwesterndaily.com.au/story/9305489/emily-capper-regional-cancer-trial-extends-life-past-prognosis/ (subscriber access)



UNSW UNSW Medicine & Health Cancer Institute NSW